Αρχική World News New Radiation Therapy Won’t Leave Breast Cancer Patients with Unwanted Tattoo at...

New Radiation Therapy Won’t Leave Breast Cancer Patients with Unwanted Tattoo at Treatment Site

Giving tattoos to people undergoing radiation therapy treatment to mark the area to be treated is standard practice in many hospitals, but it might not be for much longer. A new advancement in radiation science will hopefully eliminate the need for these unwanted and permanent markings on cancer patients’ bodies that constantly remind them of the pain of cancer treatment.“Scars fade, but tattoos don’t, so I am just so pleased I won’t have that visual reminder,” says Amanda Durack, who was recently diagnosed with early-stage breast cancer. Luckily, Durack will not have to have markers tattooed on her skin for radiation treatment.Photo: Adobe Stock/Mark Kostich
The technology, called AlignRT or surface-guided radiation therapy, is currently only available at GenesisCare’s cancer treatment centre at the Mater Hospital in Sydney, Australia. It utilizes a 3D stereoscopic camera to determine the patient’s position before and during radiation therapy to help accurately deliver the dose to the correct place on the body. This system eliminates the need to physically mark the body to ensure precision and accuracy.Photo: Adobe Stock/jcpjrFor many patients with breast cancer and other types of cancer, tattoos are the last thing on their mind, because survival and recovery are first and foremost on their to-do list. However, many patients find that after they’ve survived cancer, it’s painful to see the reminders of the terrifying ordeal etched on their skin every day. The tattoos, which are permanent and undesirable, can make it difficult for patients to return to a feeling of normalcy and confidence after cancer.
Photo: Adobe Stock/Mark Kostich“For some patients, this will eliminate the added emotional impact of having permanent ink marks, which can be an unwanted reminder of their cancer diagnosis or treatment,” says Dr. Marita Morgia, Radiation Oncologist at GenesisCare Mater Hospital.Around half of all cancer patients will receive radiation therapy as part of their treatment, making it important that the therapy be as comfortable and easy as possible. We can’t wait to see this technology become available around the world to help radiation therapy be accurate without leaving a lasting negative impact on the people it treats. What an amazing invention!
Source

NEWSLETTER

Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like
57ΑκόλουθοιΑκολουθήστε

Διαβαστε Επίσης

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ)

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...

Καρκίνος: Ευεργετική για τους καρκινοπαθείς η άσκηση

Σημαντικά ωφέλη προσφέρει η άσκηση, ακόμη και σε ασθενείς με καρκίνο. Οι περισσότεροι ασθενείς αγνοούν τα οφέλη που μπορεί να έχει γι’ αυτούς η συχνή...

Prostate Cancer

The article is provided by Scientific Communications Officer of NIPD Genetics, Ms Marina Charitou (MSc) Prostate Cancer Awareness Prostate cancer is the second most common cancer...
- Advertisment -

Ροή Ειδήσεων

EMA Recommends Granting a Conditional Marketing Authorisation for Autologous Anti-CD19-Transduced CD3+ Cells

On 15 October 2020, the European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting...

New Treatment Helps Survivors Regain Sensation After Breast Cancer

When NBC’s Kristen Dahlgren was diagnosed with breast cancer, she didn’t think much about the lack of sensation that her mastectomy would likely leave...

Is there a future without Pap testing?

Maybe you saw the hashtag #DonutTakePAPAway on social media recently? ObGyn physicians and advocates are voicing their disagreement with the American Cancer Society’s (ACS)...

Mother Spent 14 Weeks Battling Breast Cancer Alone During COVID-19 Lockdown

Battling cancer is difficult for anyone, but it’s even harder when you have to do it alone. That’s what happened to Samantha Currie. Samantha, 27,...

ESMO 2020: New Treatments for Advanced Kidney Cancer, Prostate Cancer, and Bladder Cancer

The 2020 European Society for Medical Oncology (ESMO) Virtual Congress was held online from September 19 to September 21. In this podcast, Neeraj Agarwal,...

The UK Government’s spending review: Time to invest in the future of cancer care

This autumn, the chancellor Rishi Sunak will go to Parliament and set out the UK Government’s spending priorities in the Comprehensive Spending Review...